Pathological complete response and accelerated drug approval in early breast cancer.
Office of Hematology Oncology Products, Food and Drug Administration, Silver Spring, MD, USA.
Tatiana M
TM
Prowell
Richard
R
Pazdur
D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D017277:Drug Approval; D005260:Female; D006801:Humans; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration